Project dates: 2011-2016
Evaluation of community case management of malaria in the pilot health districts of Ghombo, Gashoho, and Mabayi
To accelerate achievement of the Millennium Development Goals (MDGs) and universal health coverage, Burundi has implemented different strategies, including PECADOM, or home-based community management of malaria. A PECADOM implementation guide was developed that compiled relevant information to inform the Ministry of Public Health and the Fight against AIDS officials about its implementation. The overall goal of PECADOM is to help reduce mortality caused by malaria.This document is an external evaluation report conducted in the three districts of Gashoho, Gahombo, and Mabayi, after 24, 19, and 12 months of implementation, respectively. The following chapters present the objectives and methodology of the evaluation, the key findings, lessons learned, challenges, and conclusions and recommendations.
SIAPS’ role to control malaria was recently featured in Health & Humanitarian: The Supply Chain Review. Between 2000 and 2015, malaria case incidences declined by 41% and mortality rates by 62%. However, approximately 212 million people were infected and 429,000 people died in 2015, with the majority being children under the age of 5 in […]
SIAPS has received funding from the US President’s Malaria Initiative (PMI) to work in eight countries—Angola, Burundi, Democratic Republic of the Congo (DRC), Ethiopia, Kenya, Guinea, Mali, and South Sudan—to strengthen pharmaceutical systems for improved malaria control. This report synthesizes the pharmaceutical systems strengthening efforts of SIAPS and documents how the approach was used to support efforts to control malaria.
Defeating malaria through pharmaceutical systems strengthening: A review of SIAPS’s activities in eight countries
SIAPS recently published the results of its activities in eight countries (Angola, Burundi, the Democratic Republic of the Congo (DRC), Ethiopia, Kenya, Guinea, Mali, and South Sudan) to control malaria. This report summarizes systems strengthening interventions that support the prevention and treatment of malaria. With funding from the US President’s Malaria Initiative (PMI) and based […]
Evaluation and Expansion of Community Case Management of Malaria to Support Informed Decision Making
Working in partnership with the leadership at the MOH and the National Malaria Control Program (NMCP), SIAPS helped develop protocols and job aids for CHWs to guide them in the key steps of case management, and supported initial and refresher trainings for over 520 CHWs from the two districts. To ensure that health facilities also had sufficient capacity to provide effective support to the CHWs, SIAPS conducted additional trainings with health facility and district-level staff to create a network of support for the CCM pilot. SIAPS also helped establish a mechanism to collect and use data coming out of the pilot by building the data collection and analysis capacity of CHWs and health facility staff, and by developing a database at the district level to aggregate data from each health center. Additionally, SIAPS ensured the CHWs had the necessary equipment to provide effective CCM, including mobile telephones, bicycles, commodities boxes, gloves, cups, and spoons.
Technical Highlight: Design, Implementation, and Use of Pharmaceutical Logistics Management Information Systems (LMIS)
This technical highlight describes promising practices in assessing, designing, and implementing a LMIS based on SIAPS Program’s experience. The promising practices are supported by case examples of LMIS implementation from Bangladesh, Swaziland, and West Africa.
Systems for Improved Access to Pharmaceuticals and Services: Malaria Quarterly Update – January—March 2016
Working closely with the President’s Malaria Initiative (PMI) in both Washington and PMI- focus countries, the US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program aims to ensure the availability of quality pharmaceutical products and effective pharmaceutical services in support of PMI objectives. To this end, and based on the PMI’s priorities, SIAPS endeavors to improve pharmaceutical governance, build capacity to manage malaria products while addressing the information needed for managing them, strengthen financing strategies and mechanisms to improve access to malaria medicines, and improve the quality of pharmaceutical services provided to malaria patients.
The SIAPS technical approach emphasizes health systems strengthening with a special focus on improving metrics, monitoring and evaluation (M&E), developing the capacity of local governments and organizations, and increasing country ownership. Through this approach, SIAPS aims to promote the availability and use of malaria products, including artemisinin-based combination therapy (ACT), rapid diagnostic tests (RDT), and medicines for severe malaria. At the country level, SIAPS collaborates with national malaria control programs and Central Medical Stores (CMS) to develop and implement strategies to strengthen pharmaceutical management to prevent and improve case management of malaria. Areas supported by SIAPS include: training; quantification; strengthening supply chain systems, including logistics management information; community and malaria case management; rational use; and medication safety. SIAPS works to strengthen malaria pharmaceutical management at the national level in Angola, Burundi, the Democratic Republic of the Congo (DRC), Ethiopia, Guinea, Mali, Niger, and South Sudan. In addition, SIAPS provides regional support in Latin America.
This report describes the major activities that SIAPS conducted at the global level and in each of the countries and region mentioned above between January and March 2016.
Briggs J, Joshi MP, Yeager B, Diarra S. Ensuring access to and appropriate use of medicines for iCCM: It takes a system. Oral presentation at the 143rd American Public Health Association (APHA) Annual Meeting and Expo, Chicago, IL, USA. November 3, 2015.
According to the 2013 World Malaria Report,1 malaria incidence was reduced by about 31% and mortality rates by 49%in the World Health Organization (WHO) African Region between 2000 and 2012. These substantial reductions occurred as a result of a major scale-up of vector control interventions, diagnostic testing, and treatment with artemisinin-based combination therapies (ACTs). However, much remains to be done. The disease still took an estimated 627,000 lives in 2012,2 mostly children under five years of age in Africa.
Working closely with the President’s Malaria Initiative (PMI) both in Washington and in PMI focus countries, the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program aims to ensure the availability of quality pharmaceutical products and effective pharmaceutical services in support of PMI objectives. To this end, and based on PMI’s malaria program priorities, SIAPS endeavors to improve pharmaceutical governance, build capacity to manage malaria products while addressing the information needed for managing them, strengthen financing strategies and mechanisms to improve access to malaria medicines, and improve the quality of pharmaceutical services provided to malaria patients.
This report briefly describes the major activities that SIAPS conducted at the global level and in each of the above mentioned countries and regions between September and December 2014.
- Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program Inventory of Key Technical Resources
The main purpose of this inventory is to serve as a reference to help stakeholders working in the pharmaceutical sector […]
Project dates: 2011-2016
The end use verification (EUV) survey was conducted on December 21-30, 2017, in the departments of Zou and Collines. The […]